Skip to content

Treatment of Swarbheda with Vasadi kwath and Eladi gutika

A Clinical study on the effect of Vasadi kwath and Eladi gutika in the management of Swarbheda w. s. r. to Hoarseness of voice

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027863
Enrollment
20
Registered
2020-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R479- Unspecified speech disturbances

Interventions

Intervention1: 1.Vasadi kwath 2.Eladi gutika: 1.Vasadi kwath-40 ml in two divided doses (ref.-sha.ma.kha.2/149-150) for 14 days 2.Eladi gutika -1karsh (12gm) in the form ofcheweable tablets (ref. -ch

Sponsors

RGGPG Ayurvedic College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with signs and symptoms of Swarbheda occurring due to non specific inflammatory conditions of larynx. 2.Age above 15years irrespective of sex,caste,religion etc.

Exclusion criteria

Exclusion criteria: 1.Patient below 15years of age. 2.Paralysis of recurrent and superior laryngeal or both nerves. 3.Tumours-benign and malignant. 4.Congenital-laryngeal web, cyst, laryngocele. 5.H.O.V. occurring due to specific infections e. g. Tuberculart and fungal infections. 6.H.O.V.due to Diabetes Mellitus and Hypothyroidism. 7.Presence of other somatic or mental disorders requiring treatment. 8.Patient not willing to be registered for the trial.

Design outcomes

Primary

MeasureTime frame
Fulfillment of objective and subjective criteriaTimepoint: 7days

Secondary

MeasureTime frame
Feeling of general well-beingTimepoint: Complete feeling of wellness after 14days of trial

Countries

India

Contacts

Public ContactDr Manu Priya

RGGPG Ayurvedic College & Hospital

bhardwajvijayant@gmail.com7018026697

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026